您的位置: 首页 > 农业专利 > 详情页

UTILISATION COMBINEE D'ENZALUTAMIDE ET D'AFURESERTIB DANS LE TRAITEMENT DU CANCER
专利权人:
NOVARTIS AG
发明人:
CORNFELD, MARK J.,KUMAR, RAKESH,MORRIS, SHANNON RENAE
申请号:
CA2923899
公开号:
CA2923899A1
申请日:
2014.10.01
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
A novel combination comprising an androgen receptor inhibitor, for example: 4- (3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2- fluoro-N-methylbenzamide or a pharmaceutically acceptable salt thereof, and an AKT inhibiting compound, for example: N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5- chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide, or a pharmaceutically acceptable salt thereof, and optional additional antineoplastic agents; pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which androgen receptor inhibition and/or AKT inhibition is beneficial, e.g., cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充